Ralph Snyderman, M.D., is Chancellor Emeritus at Duke University and James B. Duke Professor of Medicine. He served as Chancellor for Health Affairs and Dean of the School of Medicine from 1989 to July 2004. During this period, he oversaw the development of the Duke University Health System, one of the most successful integrated academic health systems in the country and served as its first President and Chief Executive Officer. Dr. Snyderman has been widely recognized for his contributions to the development of more rational, effective and compassionate models of health care.

Dr. Snyderman is also the founder and chairman of Proventys, Inc., a healthcare technology company that develops risk assessment and clinical decision support tools to support personalized medicine and is a venture partner at New Enterprise Associates, based in Menlo Park, California.

Dr. Snyderman also played a leadership role in the Association of American Physicians, and the Association of American Medical Colleges. He served as chair of the AAMC in 2001-2002 and president of the Association of American Physicians in 2003-2004. In February 2009, he chaired the Institute of Medicine’s Summit on Integrative Medicine and the Health of the Public, which focused on strategies for effective health care reform that puts the patient at the center of care.

In 1987, Dr. Snyderman left Duke to join Genentech, Inc., a biomedical technology firm in San Francisco, CA, as vice president for medical research and development. A year later he was promoted to senior vice president. While at Genentech, he led the development and licensing of several novel therapeutics and supervised 300 staff members working in pharmacology, clinical research and regulatory affairs.^[1]

Snyderman has been the recipient of many honors and awards. In 2003, he received the Ellis Island Medal of Honor presented to outstanding Americans who have distinguished themselves among their specific ethnic groups and have made significant countributions to our country. He was awarded the first Bravewell Leadership Award for outstanding achievements in the field of integrative medicine in 2003. Dr. Snyderman received the 2007 Leadership in Personalized Medicine Award from the Personalized Medicine Coalition for his efforts in advancing predictive and targeted therapies on a national scale. In May 2008, he received the prestigious Industrial Research Institute’s Medal for his outstanding accomplishments in technological innovations that contribute to the development of industry and to the benefit of society. In November 2008, Dr. Snyderman was awarded Frost & Sullivan’s 2008 North American HealthCare Lifetime Achievement Award for his pioneering spirit and contributions to medicine. And, in March 2009, he received the Triangle Business Journal’s Healthcare Lifetime Achievement Award.

A graduate of Washington College in Chestertown, Maryland, Dr. Snyderman received his MD, magna cum laude, in 1965 from SUNY Downstate Medical Center. He served his internship and residency in medicine at Duke and later worked as a Public Health Officer doing research in immunology at the NIH. Dr. Snyderman has contributed to over 375 scientific manuscripts.

[edit] Board Memberships

Liquidia Technologies
National Health Museum
Novalar
Procter & Gamble, Inc.
Targacept, Inc.
Trevena, Inc.
XDx, Inc.
Washington College Board of Visitors

[edit] Scientific Societies

American Academy of Arts & Sciences
Institute of Medicine, National Academy of Sciences
Association of American Physicians
American Society for Clinical Investigation
American Association of Medical Colleges

[edit] References

1. ^ || DukeMedNews || Ralph Snyderman, MD